Pharma Rep Focus

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

tag prostate-cancer

After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. These are particularly important in the progression of certain blood cancers.

Side effects

Side effects Patients Medical Medicine

Unconventional Approaches Pharma Is Taking to Engage Patients

PM360

SEPTEMBER 7, 2023

We also put big pull tags on the little pouches that held the items. The plan is to eventually tackle other health inequity issues, such as prostate cancer in Black men, COVID in the African-American community, and bladder cancer in Black women.”

Patients

Patients Pharma Education Doctors

After a slow start for expensive CAR-T therapies, drug developers revisit oral therapies for blood cancer

Unconventional Approaches Pharma Is Taking to Engage Patients

Stay Connected